Licensing deal paves way for wider trial of OMRF Glioblastoma therapeutic

113 views · Published 27 December 2018 · 2:58 · Indexed 22 October 2026

Channel: The Oklahoman · 2018 · News & Politics

Watch on YouTube

Licensing of an investigational drug called OKN-007 developed by the Oklahoma Medical Research Foundation (OMRF) by a company focused on development and commercialization of biopharmaceutical drugs has brought hope to glioblastoma patients.

More from this channel